Labiotech.eu

News and Trends 28 Aug 2018

Update: Gilead and Novartis’s CAR T-Cell Therapies Approved in Europe

Update: Following on from earlier approvals in the US, the European Commission announced it has given marketing approval for both Gilead’s Yescarta and Novartis’s Kymriah for treatment of patients with various forms of blood cancer. Yescarta (axicabtagene ciloleucel) can be used to treat adults with a relapsed or refractory form of the blood cancer diffuse large […]

August 28, 2018 - 4 minutesmins - By Editorial Team

News and Trends 25 Aug 2018

Are Fungi the Answer to a More Sustainable Future?

The exhibition Fungal Futures, in Belgium, showcases multiple objects that are made using fungi, offering a peek into a future of sustainable materials. We are in dire need of sustainable materials that provide an environmentally-friendly alternative to plastic and other materials that cause pollution and end up crowding landfills. The solution could be fungi. These […]

August 25, 2018 - 5 minutesmins - By Clara Rodríguez Fernández

More News! 24 Aug 2018

Shire gets US market approval for rare inflammatory disease drug

The UK-US biotech giant’s drug Takhzyro has been approved by the FDA to prevent attacks of hereditary angioedema, a rare genetic disease that causes swelling around the body. Hereditary angioedema is a potentially life threatening genetic condition that people can inherit from either of their parents. Takhzyro (lanadelumab-flyo) is a first-in-class monoclonal antibody drug that […]

August 24, 2018 - 2 minutesmins - By Helen Albert

News and Trends 22 Aug 2018

Swedish Biotech Breaks Barrier to Diagnosis with Rheumatoid Arthritis Test

A blood test developed by Swedish-biotech Immunovia and scientists from Linköping University accurately diagnoses patients with rheumatoid arthritis even if they test negative for two common biomarkers. The current gold standard test for rheumatoid arthritis, which affects 5-7 million people in the US and Europe, misses a substantial number of people who have the condition. […]

August 22, 2018 - 2 minutesmins - By Helen Albert

sea view plus seaweed marine biofuel news

More News! 22 Aug 2018

Producing Cost-Effective and Eco-Friendly Biofuel With Seawater

UK researchers have developed a technique for making bioethanol from seawater, which they hope will make production of the biofuel cheaper and more environmentally friendly than current methods. At present, bioethanol production uses very large amounts of freshwater – 1000-10,000 liters water per 1 liter bioethanol. They also require large amounts of plant biomass to […]

August 22, 2018 - 3 minutesmins - By Helen Albert

Best in Biotech 20 Aug 2018

Here are our 10 favorite biotech books you should read this summer

Here is a list of our 10 best biotech books for you, ranging from new and classic popular science to science fiction, as selected by the team at Labiotech. The summer is sadly coming to a close very soon, but we wanted to provide you with a bit more Labiotech entertainment for its last few weeks. I […]

August 20, 2018 - 9 minutesmins - By Helen Albert

News and Trends 17 Aug 2018

Novo Nordisk Buys British ‘Smart’ Insulin Diabetes Biotech in deal worth €702M

Novo Nordisk acquired the UK biotech Ziylo, which develops glucose-responsive insulin treatments for diabetes that act in response to changes in blood sugar levels. The Danish big-pharma, which is already a big player in the diabetes space, acquired the full rights to Ziylo’s technology in a deal worth up to €702M ($800M). Novo will use the […]

August 17, 2018 - 2 minutesmins - By Alexander Burik

Startup Scout 17 Aug 2018

This Italian Biotech Makes Wood-Derived Bone Implants

Today, we’re in Faenza, Italy, visiting GreenBone, a biotech developing wood-derived bone implants for patients with bone fractures. Mission: Founded in 2014, GreenBone takes bamboo and converts it to a calcium compound called hydroxyapatite. The material could be used as an alternative to bone grafts made from a deceased donor or bone taken from another […]

August 17, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 16 Aug 2018

Pfizer Offers €374M for German mRNA Flu Vaccine

BioNTech, based in Mainz, Germany, has entered into a partnership with Pfizer worth up to $425M (€374M) to develop an mRNA-based flu vaccine, which could be produced much more quickly than current flu vaccines. Messenger RNA (mRNA) is one of the building blocks living organisms use to create proteins from genes. BioNTech is developing prophylactic […]

August 16, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 15 Aug 2018

London Biotech Gets Positive Phase III Results for its Monthly HIV Treatment

ViiV Healthcare has shown its monthly two-drug HIV treatment works as well as a daily three-drug treatment, which could help reduce the total number of drugs taken by patients. In a Phase III trial that recruited 618 people, London biotech ViiV Healthcare aimed to see if adult HIV-positive patients who had been taking daily antiretroviral […]

August 15, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 13 Aug 2018

Orchard Therapeutics Raises €132M to Develop Gene Therapies

Orchard Therapeutics raised $150M (€132M) in Series C financing to bring its gene therapies from clinical testing to regulatory approval. The British biotech will use the funding to develop its most advanced clinical programs, which aim to treat rare inherited metabolic and immune system diseases. The news follows Orchard’s acquisition of GSK’s entire gene therapy […]

August 13, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 11 Aug 2018

Culturing Bacteria in a Lifesize Human Body Sculpture

Artist Mellissa Fisher built a human sculpture carrying the myriad of invisible bacteria that live on our bodies to highlight the global threat of antibiotic resistance. Journalist Michael Mosley enters the lab and sees a replica of his own body. All over it, bacteria of all sizes and colors grow, competing with each other to […]

August 11, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Update: Gilead and Novartis’s CAR T-Cell Therapies Approved in Europe

Are Fungi the Answer to a More Sustainable Future?

Shire gets US market approval for rare inflammatory disease drug

Swedish Biotech Breaks Barrier to Diagnosis with Rheumatoid Arthritis Test

Producing Cost-Effective and Eco-Friendly Biofuel With Seawater

Here are our 10 favorite biotech books you should read this summer

Novo Nordisk Buys British ‘Smart’ Insulin Diabetes Biotech in deal worth €702M

This Italian Biotech Makes Wood-Derived Bone Implants

Pfizer Offers €374M for German mRNA Flu Vaccine

London Biotech Gets Positive Phase III Results for its Monthly HIV Treatment

Orchard Therapeutics Raises €132M to Develop Gene Therapies

Culturing Bacteria in a Lifesize Human Body Sculpture

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!